Gina Consylman is Chief Financial Officer of bluebird bio, Inc.. Currently has a direct ownership of 125,385 shares of BLUE, which is worth approximately $1.07 Million. The most recent transaction as insider was on Feb 01, 2022, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0% 3M change
0% 12M change
Total Value Held $1.07 Million

Gina Consylman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 16.62%
125,385 Common Stock
Nov 11 2021
BUY
Other acquisition or disposition
-
100,385 Added 50.0%
100,385 Common Stock

Also insider at

ASMB
ASSEMBLY BIOSCIENCES, INC. Healthcare
IRWD
IRONWOOD PHARMACEUTICALS INC Healthcare
VSTM
Verastem, Inc. Healthcare
GC

Gina Consylman

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE